论文部分内容阅读
目的:分析门冬胰岛素30注射液治疗老年2型糖尿病的临床效果。方法:研究对象为我院2013年1月至2014年6月期间收治的80例2型糖尿病老年病患治疗案例,分为对照组和观察组各40例,其中对照组使用常规二甲双胍干预治疗,观察组运用门冬胰岛素30注射液治疗,而后分析其治疗不良反应和血糖变化情况。结果:在血糖情况指数变化上,观察组治疗后的改善幅度均优于对照组;在治疗不良反应上,观察组为2.5%,对照组为12.5%。结论:在治疗2型糖尿病老年病患的治疗上,运用门冬胰岛素30注射液可以达到较高水平的血糖相关指标改善,同时降低治疗中的不良反应,病患治疗的接受情况较好。
Objective: To analyze the clinical effect of insulin aspart 30 in the treatment of type 2 diabetes in the elderly. Methods: The subjects were 80 cases of type 2 diabetes mellitus treated in our hospital from January 2013 to June 2014, divided into control group and observation group of 40 cases, the control group were treated with metformin, The observation group treated with insulin aspart 30 injection, and then analyzed the treatment of adverse reactions and blood glucose changes. Results: In the changes of blood glucose index, the improvement rate of the observation group after treatment was better than that of the control group. In the adverse reactions, the observation group was 2.5% and the control group was 12.5%. Conclusion: In the treatment of elderly patients with type 2 diabetes, the use of insulin aspart 30 injection can achieve a higher level of blood glucose-related indicators to improve, while reducing the adverse reactions in treatment, the treatment of patients receiving better.